Allergic diseases in the elderly

Clinical and Translational Allergy

Teresa Garriga²  Anna Sala-Cunill¹  Moises Labrador-Horrillo¹  Olga Luengo¹  Mar Guilarte¹  Victoria Cardona¹ 

[1] Allergy Research Unit, Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona, Spain;Allergy Section, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain

关键词: dermatitis;    pharmacotherapy;    drug allergy;    immunosenescence;    aging population;    elderly;    asthma;    Allergy;   

Others  :  794775
DOI  :  10.1186/2045-7022-1-11

 received in 2011-08-22, accepted in 2011-10-17,  发布年份 2011

【 摘 要 】

Demographic distribution of the population is progressively changing with the proportion of elderly persons increasing in most societies. This entails that there is a need to evaluate the impact of common diseases, such as asthma and other allergic conditions, in this age segment. Frailty, comorbidities and polymedication are some of the factors that condition management in geriatric patients. The objective of this review is to highlight the characteristics of allergic diseases in older age groups, from the influence of immunosenescence, to particular clinical implications and management issues, such as drug interactions or age-related side effects.

【 授权许可】

   
2011 Cardona et al; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Mathur SK: Allergy and asthma in the elderly. Semin Respir Crit Care Med 2010, 31(5):587-95.
• [2]Kuokkanen L: Drugs eruptions: a series of 464 cases in the Department of Dermatology University of Tineku, Finland during 1966-1970. Acta Allergol 1972, 24:407.
• [3]Mallet L, Spinewine A, Huang A: The challenge of managing drug interactions in elderly people. Lancet 2007, 370:185.
• [4]Gomez CR, Nomellini V, Faunce DE, Kovacs EJ: Innate immunity and aging. Exp Gerontol 2008, 43(8):718-28.
• [5]Busse PJ, Mathur SK: Age-related changes in immune function: effect on airway inflammation. J Allergy Clin Immunol 2010, 126(4):690-9.
• [6]Dunn-Walters DK, Ademokun AA: B cell repertoire and aging. Curr Opin Immunol 2010, 22(4):514-20.
• [7]Pawelec G: Immunosenescence comes of age. Symposium on Aging Research in Immunology: The Impact of Genomics. EMBO Rep 2007, 8(3):220-3.
• [8]Mocchegiani E, Malavolta M, Costarelli L, Giacconi R, Cipriano C, Piacenza F, Tesei S, Basso A, Pierpaoli S, Lattanzio F: Zinc, metallothioneins and immunosenescence. Proc Nutr Soc 2010, 69(3):290-9.
• [9]Pietschmann P, Woloszczuk W, Pietschmann H: Increased serum osteocalcin levels in elderly females with vitamin D deficiency. Clin Exp Endocrinol 1990, 95:275-278.
• [10]Chambers ES, Hawrylowicz CM: The impact of Vitamin D on Regulatory T Cells. Curr AllergyAsthma Rep 2011, 11:29-36.
• [11]Hyppönen E, Berry DJ, Wjst M, Power C: Serum 25-hydroxyvitamin D and IgE - a significant but nonlinear relationship. Allergy 2009, 64:613-620.
• [12]Scichilone N, Callari A, Augugliaro G, Marchese M, Togias A, Bellia V: The impact of age on prevalence of positive skin prick tests and specific IgE tests. Respir Med 2011, 105(5):651-8.
• [13]Mediaty A, Neuber K: Total and specific serum IgE decreases with age in patients with allergic rhinitis, asthma and insect allergy but not in patientswith atopic dermatitis. Immun aging 2005, 2(1):9. BioMed Central Full Text
• [14]Gergen PJ, Turkeltaub PC, Kovar MG: The prevalence of allergic skin test reactivity to eight common aeroallergens in the U.S. population: results from the second National Health and Nutrition Examination Survey. J Allergy Clin Immunol 1987, 80(5):669-79.
• [15]Barbee RA, Kaltenborn W, Lebowitz MD, Burrows B: Longitudinal changes in allergen skin test reactivity in a community population sample. J Allergy Clin Immunol 1987, 79:16.
• [16]Scichilone N, Augugliaro G, Togias A, Bellia V: Should atopy be assessed in elderly patients with respiratory symptoms suggestive of asthma? Expert RevRespir Med 2010, 4(5):585-91.
• [17]Sahin Yilmaz AA, Corey JP: Rhinitis in the elderly. Curr Allergy Asthma Rep 2006, 6(2):125-31.
• [18]Lindermann J, Sannwald D, Wiesmiller K: Age-related changes in intranasal air conditioning in the elderly. Laryngoscope 2008, 188:8-1472.
• [19]Kirtsreesakul V, Somjareonwattana P, Ruttanaphol S: The correlation between nasal symptom and mucociliary clearance in allergic rhinitis. Laryngoscope 2009, 119(8):1458-62.
• [20]Hanania NA, King MJ, Braman SS, Saltoun C, Wise RA, Enright P, Falsey AR, Mathur SK, Ramsdell JW, Rogers L, Stempel DA, Lima JJ, Fish JE, Wilson SR, Boyd C, Patel KV, Irvin CG, Yawn BP, Halm EA, Wasserman SI, Sands MF, Ershler WB, Ledford DK, Asthma in the Elderly workshop participants: Asthma in the elderly: Current understanding and future research needs-a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol 2011, 128(3 Suppl):S4-S24.
• [21]Grundmann SA, Ständer S: Evaluation of chronic pruritus in older patients. Aging Health 2010, 6:53-66.
• [22]Farage MA, Miller KW, Elsner P, Maibach HI: Functional and physiological characteristics of the aging skin. Aging Clin Exp Res 2008, 20:195-200.
• [23]Czernielewski JM, Masouye I, Pisani A, Ferracin J, Auvolat D, Ortonne JP: Effect of chronic sun exposure on human Langerhans cell densities. Photodermatol 1988, 5(3):116-20.
• [24]Balato A, Balato N, Costanzo L, Ayala F: Contact sensitization in the elderly. Clinics in Dermatology 2011, 29:24-30.
• [25]De Faria AM, Ficker SM, Speziali E, Menezes JS, Stransky B, Silva Rodrigues V, Vaz NM: Aging affects oral tolerance induction but not its maintenance in mice. Mech aging Dev 1998, 102:67-80.
• [26]Thoreaux K, Owen RL, Schmucker DL: In,101testinal lymphocyte munber, migration and antibody secretion in young and old rats. Immunology 2000, 101:161-167.
• [27]Ahluwalia N, Sun J, Krause D, Mastro A, Handte G: Immune function is impaired in iron-deficient, homebound, older women. Am J Clin Nutr 2004, 79:516-521.
• [28]Ma TY, Hollander D, Dadufalzav V, Krugliak P: Effect of aging and caloric restriction on intestinal permeability. Exp Gerontology 1992, 27:321-333.
• [29]Saweirs WM, Andrews DJ, Low-Beer TS: The double sugar test of intestinal permeability in elderly. Age aging 1985, 14:312-315.
• [30]Persson J: Alcohol and the small intestine. Scand J Gastroenterol 1991, 26:3-15.
• [31]Bakos N, Schöll I, Szalai K, Kundi M, Untersmayr E, Jensen-Jarolim E: Risk assessment in elderly for sensitization to food and respiratory allergens. Immunol Lett 2006, 107(1):15-21.
• [32]Mullin Jm, Valenzano MC, Whitby M, Lurie D, Schmidt JD, Jain V, Tully O, Kearney K, Lazowick D, Mercogliano G, Thornton JJ: Esomeprazole induces upper gastrointestinal tract transmucosal permeability increase. Aliment Pharmacol Ther 2008, 28:1317-1325.
• [33]Untersmayr E, Jensen-Jarolim E: The role of protein digestibility and antiacids on food allergy outcomes. J allergy Clin Immunol 2008, 121:1301-1308.
• [34]Pinto JM, Jeswani S: Rhinitis in the geriatric population. Allergy Asthma Clin Immunol 2010, 6(1):10. BioMed Central Full Text
• [35]Bauchau V, Durham SR: Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004, 24:758-64.
• [36]Singh K, Axelrod S, Bielory L: The epidemiology of ocular and nasal allergy in the United States, 1988-1994. J Allergy Clin Immunol 2010, 126(4):778-783.
• [37]Slavin RG: Special considerations in treatment of allergic rhinitis in the elderly: role of intranasal corticosteroids. Allergy Asthma Proc 2010, 31(3):179-84.
• [38]Gibson PG, McDonald VM, Marks GB: Asthma in older adults. Lancet 2010, 376(9743):803-13.
• [39]Luks VP, Vandemheen KL, Aaron SD: Confirmation of asthma in an era of overdiagnosis. Eur Respir J 2010, 36(2):255-60.
• [40]Enright PL, McClelland RL, Newman AB, Gottlieb DJ, Lebowitz MD: Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group. Chest 1999, 116(3):603-13.
• [41]Barua P, O'Mahony MS: Overcoming gaps in the management of asthma in older patients: new insights. Drugs Aging 2005, 22(12):1029-59.
• [42]Bellia V, Catalano F, Pistelli R, Antonelli-Incalzi R: Aging on quality of spirometry. Am J Respir Crit Care Med 2004, 170(1):100.
• [43]García-Río F, Pino JM, Dorgham A, Alonso A, Villamor J: Spirometric reference equations for European females and males aged 65-85 yrs. Eur Respir J 2004, 24(3):397-405.
• [44]Chanez P, Vignola AM, O'Shaugnessy T, Enander I, Li D, Jeffery PK, Bousquet J: Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med 1997, 155(5):1529-34.
• [45]Ward JR, Bernhard JD: Willan's itch and other causes of pruritus in the eldery. Int J dermatol 2005, 44:267-73.
• [46]Beauregard S, Gilchrest BA: A survey of skin problems and skin care regimens in the elderly. Arch Dermatol 1987, 123(12):1638-43.
• [47]Norman RA: Xerosis and pruritus in the elderly: recognition and management. Dermatol ther 2003, 16(3):254-9.
• [48]Reich A, Ständer S, Szepietowski JC: Pruritus in the elderly. Clin Dermatol 2011, 29(1):15-23.
• [49]Misery L, Wallengren DJ, Wisshaar E, Zalewska A: Validation of diagnosis criteria of functional itch disorder or psychogenic pruritus. Acta Derm Venereol 2008, 88:503-4.
• [50]Reich A, Ständer S, Szepietowski JC: Drug-induced pruritus:a review. Acta Derm Venereol 2009, 89:236-44.
• [51]Piaserico S, Larese F, Recchia GP, Corradin MT, Scardigli F, Gennaro F, Carriere C, Semenzato A, Brandolisio L, Peserico A, Fortina AB, North-East Italy Contact Dermatitis Group: Allergic contact sensitivity in elderly patients. Aging Clin Exp Res 2004, 50:379-81.
• [52]Onder M, Orhan Oztas M: Contact dermatitis in the elderly. Contact Dermatitis 2003, 48:232-3.
• [53]Wantke F, Hemmer W, Jarisch R, Gotz m: Patch test reaction in children, adults and the elderly. Contact Dermatitis 1996, 34:316-9.
• [54]Margolis DJ, Bilker W, Santanna J, Baumgarten M: Venous leg ulcer: incidence and prevalence in the elderly. J Am Acad Dermatol 2002, 46:381-6.
• [55]Nedorost S, Stevens S: Diagnosis and Treatment of Allergic Skin Disorders in the Elderly. Drug Aging 2001, 18(11):827-835.
• [56]Isaksson M, Bruze M, Björkner B, Hindsén M, Svensson L: The benefit of patch testing with a corticosteroid at a low concentration. Am J Contact Derm 1999, 10(1):31-3.
• [57]Reitschel RL, Flowler JF, editors: Fisher's contact dermatitis. 5th edition. Philadelphia: Lippincott, Williams and Wilkins; 2001.
• [58]MacKenzie-Wood AR, Freeman S: Unclassified endogenous eczema. Contact Derm 1999, 41(1):18-21.
• [59]Cicardi M, Bisiani G, Cugno M, Spath P, Agostoni A: Autoimmune C1 inhibitor deficiency: report of eight patients. Am J Med 1993, 95:169-75.
• [60]Malde B, Regalado J, Greenberger PA: Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Ann Allergy Asthma Immunol 2007, 98:57-63.
• [61]Vleeming W, van Amsterdam JG, Stricker BH, de Wildt DJ: ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf 1998, 18:171-88.
• [62]Campbell Rl, Hagan JB, LI JTC, Vukov Sc, Kanthala AR, Smith VD, Manivannan V, Bellolio MF, Decker WW: Anaphylaxis in emergency department in patients 50 or 65 or older. Ann Allergy Asthma Immunol 2011, 106:401-406.
• [63]Cunningham G: Adverse drug reactions in the elderly and their prevention. Scott Med J 1997, 42(5):136-7.
• [64]World Health Organization: health care in the elderly Drugs 1981, 22:279-94.
• [65]Gurwitz JH, Avorn J: The ambiguous relation between aging and adverse drug reactions. Ann Intern Med 1991, 31:101-28.
• [66]Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, Seger DL, Shu K, Federico F, Leape LL, Bates DW: Adverse drug events in ambulatory care. N Engl J Med 2003, 348:1556-64.
• [67]Turnheim K: Drug dosage in the elderly. Is it rational? Drugs and aging 1998, 13(5):357-79.
• [68]Beijer HJ, de Blaey CJ: Hospitalisations caused by adverse drug reactions: a meta-analysis of observational Studies. Pharm World Sci 2002, 24-46.
• [69]Lazarou J, Pomeranz BH, Corey PN: Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998, 279:1200.
• [70]Budnitz DS, Shehab N, Kegler SR, Richards CL: Medication use leading to emergency department visits for adverse drug events I older adults. 2007, 147(11):755-65.
• [71]Demoly R, Romano A: Update on beta-lactam allergy diagnosis. Curr Allergy Asthma Rep 2005, 5:9-14.
• [72]Manfredi M, Severino M, Testi S, Severino M, Testi S, Macchia D, Ermini G, Pichler WJ, Campi P: Detection of specific IgE to quinolones. J Allergy Clin Immunol 2004, 113-155.
• [73]Namazy JA, Simon RA: Sensitivity to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 2002, 89-542.
• [74]Baldo BA, Fisher MM, Pham NH: On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs: an immunochemical perspective. Clin Exp Allergy 2009, 325.
• [75]Pichler WJ: Delayed drug hypersensitivity reactions. Ann Intern Med 2003, 139(8):683-93.
• [76]Devons CA: Comprehensive geriatric assessment: making the most of the aging years. Curr Opin Clin Nutr Metab Care 2002, 5:19.
• [77]Stuck AE, Siu AL, Wieland GD, Adams J, Rubenstein LZ: Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet 1993, 342(8878):1032-6.
• [78]Kuo HK, Scandrett KG, Dave J, Mitchell SL: The influence of outpatient comprehensive geriatric assessment on survival: a meta-analysis. Arch Gerontol Geriatr 2004, 39(3):245-54.
• [79]Maggiore RJ, Gross CP, Hurria A: Polypharmacy in older adults with cancer. Oncologist 2010, 15(5):507-22.
• [80]Hall MRP: Drug interactions in the elderly. J Am Geriatr Soc 1982, 28(Suppl 1):18-24.
• [81]Seymour R, Routledge A: Important Drug-Drug Interactions in the Elderly. Drug & Aging 1998, 12(6):485-496.
• [82]Hansen J, Klimek L, Hörmann K: Pharmacological management of allergic rhinitis in the elderly: safety issues with oral antihistamines. Drugs Aging 2005, 22(4):289-96.
• [83]Yilmaz AAS, Corey JP: Rhinitis in the elderly. Curr Allergy Asthma Rep 2006, 61:125-131.
• [84]Slavin RG, Haselkorn T, Lee JH, Zheng B, Deniz Y, Wenzel SE, TENOR Study Group: Asthma in older adults: observations from the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study. Ann Allergy Asthma Immunol 2006, 96(3):406-14.
• [85]Bian B, Kelton CM, Wigle PR, Guo JJ: Evaluating safety of long-acting beta agonists (LABAs) in patients with asthma. Curr Drug Saf 2010, 5(3):245-50.
• [86]Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ: Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev 2010, (5):CD005535.
• [87]Pesek R, Lockey R: Vaccination of adults with asthma and COPD. Allergy 2011, 66(1):25-31.
• [88]Szepietowski JC, Reich A: Pruritus: pathomechanism, clinics, treatment. Poznan: Termedia Publishing House; 2010.
• [89]Drake LA, Fallon JD, Sober A: Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group. J Am Acad Dermatol 1994, 31:613-6.
• [90]Duque MI, Yosipovitch G, Fleischer AB Jr, Willard J, Freedman BI: Lack of efficacy of tracrolimus ointment 0,1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle controlled study. J Am Acad Dermatol 2005, 52:519-21.
• [91]Stander S, Reinhardt HW, Luger TA: Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus. Hautarzt 2006, 57(9):801-7.
• [92]Patel T, Yosipovitch G: The Management of Chronic Pruritus in the Elderly. Skin Therapy Letter 2010, 15(8):5-10.
• [93]Szepietowski JC, Morita A, Tsuji T: Ultraviolet B induces mast cell apoptosis: a hypothetical mechanism of ultraviolet B treatment for uraemic pruritus. Med Hypotheses 2002, 58:167-70.
• [94]Simons FER, Fraser TG, Maher J, Pillay N, Simons KJ: Central nervous system effects of H1-receptor antagonists in the elderly. Ann Allergy Asthma Immunol 1999, 82:157-160.
• [95]Agostini JV, Leo-Summers LS, Inouye SK: Cognitive and other adverse effects of diphenhydramine use in hospitalized older patients. Arch Intern Med 2001, 161(17):2091-7.
• [96]Simons FER: Advances in H1-antihistamines. N Engl J Med 2004, 351:2203-2217.
• [97]Breton G, Froissart M, Janus N, Launay-Vacher V, Berr C, Tzourio C, Helmer C, Stengel B: Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function--the Three-City population-based study. Nephrol Dial Transplant 2011, 26(9):2852-9.
• [98]Simons FE: Comparative pharmacology of H1 antihistamines: clinical relevance. Am J Med 2002, 113(Suppl 9A):38S-46S.
• [99]Affrime M, Gupta S, Banfield C, Cohen A: A pharmacokinetic profile of desloratadine in healthy adults, including elderly. Clin Pharmacokinet 2002, 41(Suppl 1):13-9.
• [100]Flammiger A, Maibach H: Drug Dosage in the Elderly. Drugs Aging. 2006, 23(3):203-215.
• [101]Keenan PA, Jacobson MW, Soleymani RM, Mayes MD, Stress ME, Yaldoo DT: The effect of memory of chronic prednisone treatment in patients with systemic disease. Neurology 1996, 47(6):1396-402.
• [102]Blackburn D, Hux J, Mamdani M: Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly. J Gen Intern Med 2002, 17:717-20.
• [103]Piper JM, Ray WA, Daugherty JR, Griffin MR: Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflamatory drugs. Ann Intern Med 1991, 114:735-40.
• [104]Wang JJ, Rochtchina E, Tan AG, Cumming RG, Leeder SR, Mitchell P: Use of inhaled and oral corticosteroids and the long-term risk of cataract. Ophthalmology 2009, 116(4):652-7.
• [105]Weinstein RS: Clinical practice. Glucocorticoid-induced bone disease. N Engl J Med 2011, 365(1):62-70.
• [106]Liu WM, Zeijst BA, Boog CJ, Soethout EC: Aging and impaired immunity to influenza viruses: Implications for vaccine development. Hum Vaccin 2011, 7.
• [107]Armentia A, Fernández A, Tapias JA, Méndez J, de la Fuente R, Sánchez-Palla P, Sanchís E: Immunotherapy with allergenic extracts in geriatric patients: evaluation of effectiveness and safety. Allergol Immunopathol (Madr) 1993, 21(5):193-6.
• [108]Asero R: Efficacy of injection immunotherapy with ragweed and birch pollen in elderly patients. Int Arch Allergy Immunol 2004, 135(4):332-5.
• [109]Marogna M, Bruno ME, Massolo A, Falagiani P: Sublingual immunotherapy for allergic respiratory disease in elderly patients: a retrospective study. Eur Ann Allergy Clin Immunol 2008, 40(1):22-9.